查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1634625

生物加工袋市场：现况分析与未来预测（2024-2032）

Bioprocess Bags Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计预测期内（2024-2032 年），生物处理袋市场将以 17.5% 的显着复合年增长率成长。生物处理袋市场的成长反映了全球生物製药製造中使用一次性技术的趋势。这些产业享有许多好处，例如缩短了交货时间、降低了污染机率、提高了生产力。生物处理袋市场的扩张是由对生物製剂、生物相似药和疫苗的不断增长的需求所推动的。 2022 年 10 月，奥地利解决方案供应商 Single Use Support GmbH 扩大了产品组合，推出了一系列名为 IRIS 的新型一次性生物处理容器。作为先驱者，该公司继续推行与供应商无关的方法，利用其专业知识在生物製药流体管理领域提供可靠的流程解决方案。

根据类型，市场分为 2D 生物处理袋、3D 生物处理袋和其他。其中，2D 生物处理袋将在 2023 年占据市场的主导占有率，因为 2D 生物处理袋解决方案将透过生物製药製造中经济且节省空间的流体管理推动成长。生物製药製造中的流体管理经济且节省空间，由于生物製药製造中流体管理的经济性和空间效率，推动了成长。这些解决方案适用于在您的製程中储存和运输培养基、缓衝液和中间产品，具有完全无菌性和灵活性。例如，2023 年 7 月，医疗和生物製药行业 OEM 一次性组件的全球供应商 Qosina 宣布已收购 Entegris 的 Aramus 2D 袋，后者是半导体和其他高高科技製造业。 。

根据产品类型，市场分为一次性生物处理袋和多次使用生物处理袋。一次性生物处理袋受生产规模快速扩大、清洁频率减少和交叉污染风险低的推动，在 2023 年占据了相当大的市场占有率。此外，由于它们对培养基製备、混合和产品储存等生物加工的适应性，公司正在生物加工中使用这些袋子。它对自动化生物反应器和封闭系统的适应性使其成为现代生物製造业的基石。例如，2022 年 3 月 28 日，专门为生物製药和製药加工提供创新一次性解决方案的 ILC Dover LP（ "ILC Dover" 或 "公司" ）宣布推出其液体一次性生物处理袋。宣布。此次扩展延续了 ILC Dover 的解决方案集，涵盖了整个生物治疗和製药製造工作流程，从粉末容纳和处理到无菌液体处理和预填充液体和粉末袋。

根据工作流程，市场分为上游处理、下游处理、流程开发和媒体准备。预计预测期内（2024-2032 年），下游加工将以显着的复合年增长率成长。下游加工的这一环节透过为製程的产品净化步骤提供安全有效的多产品流体处理解决方案来促进成长。组织使用这些袋子来最大限度地减少营运中断并促进符合高标准品质的生产。与色谱和过滤结合，可以提高生物製剂的产量和纯度。

根据最终用户，市场细分为製药和生物製药公司、CMOS 和 CROS 以及学术和研究机构。预计 CMOS/CROS 在预测期内（2024-2032 年）将以显着的复合年增长率成长。 CMO/CRO是[CRO（合约研究组织）/CMO（合约製造组织）]的缩写，并引入生物加工袋，以大规模和实惠的价格提供生物加工生产服务。这些组织依赖一次性系统（如生物製程袋），因为它们在生物製剂和生物相似药的生产中具有多功能性。

为了更瞭解生物工艺袋的市场介绍，该报告涵盖了北美（美国、加拿大和北美其他地区）、欧洲（德国、法国、英国、西班牙、义大利和欧洲其他地区） 、亚太地区（中国、日本、韩国、印度、亚太地区其他地区）和其他地区的全球影响力是市场分析的基础。预计预测期内（2024-2032 年）亚太地区将实现显着的复合年增长率。这是由于中国和印度等新兴强国的生物技术产业蓬勃发展以及生物製药消费量激增。由于政府政策支持低製造成本的本地生产，该地区是最重要的生物加工中心之一。增加一次性技术的支出和透过 CMO/CRO 增加 CMC 服务的外包是关键推动因素。公司选择遵守生物加工袋的国际品质标准的原因有很多，其中包括扩大生物相似药和疫苗生产规模的需要。此外，该地区对新技术和出口导向生物製造的关注进一步支持了其采用。 2021 年6 月1 日，Avantor, Inc. (NYSE: AVTR) 是一家为生命科学、先进技术和应用材料行业的客户提供关键任务产品和服务的全球领先供应商，今天宣布已收购Avantor, Inc 的一家子公司.，一家全资子公司...宣布收购中国领先的一次性生物处理袋和组件製造商 RIM Bio。

市场包括Thermo Fisher Scientific Inc.、Sartorius AG、Merck KGaA、Saint-Gobain、Avantor, Inc.、Corning Incorporated、Lonza Group Ltd.、Entegris、Meissner Filtration Products, Inc.、Charter Medical (Solesis)等。

目录

第一章 市场介绍

  • 市场定义
  • 主要目的
  • 利害关係人
  • 限制

第 2 章 研究方法或假设

  • 研究过程
  • 研究方法
  • 受访者资料

第 3 章执行摘要

  • 产业摘要
  • 各细分市场的展望
    • 市场成长强劲
  • 区域展望

第 4 章 市场动态

  • 驱动程式
  • 机会
  • 阻碍因素
  • 趋势
  • PESTEL 分析
  • 需求方分析
  • 供给面分析
    • 合併和收购
    • 投资场景
    • 产业洞察：领先的新创公司及其独特策略

第 5 章 定价分析

  • 按地区进行价格分析
  • 影响价格的因素

第六章 2022-2032 年全球生物加工袋市场收入

第 7 章 市场洞察：按类型

  • 2D生物处理袋
  • 3D生物製程袋
  • 其他

第 8 章。
  • 一次生物处理袋
  • 多用途生物处理袋

第 9 章 市场洞察：依工作流程

  • 上游流程
  • 下游工艺
  • 製程开发
  • 培养基製备

第 10 章 终端使用者的市场洞察

  • 製药和生物製药公司
  • CMO 和 CRO
  • 学术研究机构

第 11 章市场洞察：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区

第 12 章 价值链分析

  • 市场参与者名单

第 13 章 竞争格局

  • 竞争资讯中心
  • 竞争市场定位分析
  • 波特五力分析

第 14 章 公司简介

  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 主要财务数据
    • SWOT 分析
    • 产品组合
    • 最新动态
  • Sartorius AG
  • Merck KGaA
  • Saint-Gobain
  • Avantor, Inc.
  • Corning Incorporated
  • Lonza Group Ltd.
  • Entegris
  • Meissner Filtration Products, Inc.
  • Charter Medical（Solesis）

第 15 章 缩写与先决条件

第 16 章附录

简介目录
Product Code: UMHE213122

Bioprocess bags are disposable polymeric sacks used in the processing, storage, and transportation of the liquid or media in biopharmaceutical industries. These bags help maintain sterility, are scalable, and engraved to reduce contamination. This includes upstream and downstream processes when producing chemicals and the final formulation stage with high-quality polymer material. They are essential to all current bioprocessing strategies due to the productivity and, even more so, the affordability of these supports.

The Bioprocess Bags Market is expected to grow with a significant CAGR of 17.5% during the forecast period (2024-2032). The growth of the bioprocess bags market reflects the global trend towards the usage of single-use technologies in biopharmaceutical production. These industries avail themselves by minimized lead time, decreased probability of contamination, and improved production. The bioprocess bags market expansion is fueled by the increasing need for biologics, biosimilars, and vaccines. In October 2022, Austrian solution provider Single Use Support GmbH expanded its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how to provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach.

Based on the type, the market is segmented into 2D Bioprocess Bags, 3D Bioprocess Bags, and others. Among these, 2D Bioprocess Bags held a dominant share of the market in 2023 because the solutions of the 2D bioprocess bags promote growth through economical and space-efficient fluid management in biopharmaceutical production. They are suitable to be used for storage and transportation of media, buffers as well as intermediate products in the process with total sterility and flexibility. For instance, in July 2023, Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, announced the addition of Aramus 2D bag chambers from Entegris, a leading supplier of advanced materials and process solutions for semiconductors and other high-tech manufacturing industries.

Based on product type, the market is segmented into single-use bioprocessing bags and multi-use bioprocessing bags. Single-use bioprocessing bags held a significant share of the market in 2023 owing to enhanced growth by facilitating rapid production scaling, the need to clean them less often, and possessing lower risk of cross-contamination. Adding to this, companies use these bags in bioprocessing due to their adaptability to bioprocesses such as media preparation, mixing, and product storage. Their adaptability to automated bioreactors and closed systems makes them fundamental to the current biomanufacturing industry. For instance, on March 28, 2022 - ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover's solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder containment and handling, through sterile liquid handling and pre-filled liquid and powder bags.

Based on the workflow, the market is segmented into upstream process, downstream process, process development, and media preparation. The downstream process is expected to grow with a significant CAGR during the forecast period (2024-2032. This segment in downstream processing enables growth by providing safe and effective multi-product fluid-handling solutions for product purification steps in the process. These bags are embraced in organizations to minimize pauses in operation and facilitate production to meet high standard quality. In combination with chromatography and filtration, it raises the production yield and purity of biological products.

Based on the end user, the market is segmented into pharmaceutical & biopharmaceutical companies, CMOS & CROS, and academic & research institutes. The CMOS & CROS is expected to grow with a significant CAGR during the forecast period (2024-2032. CMOs/CROs stands [Contract research organizations (CROs), contract manufacturing organizations (CMOs)] enable growth through the implementation of bioprocess bags for contained bioprocessing of production services at scale and affordable rates. These organizations depend on single-use systems - such as bioprocess bags - as these provide production versatility in biologics and biosimilars.

For a better understanding of the market adoption of Bioprocess Bags, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is due to the booming biotechnology industry and rapidly growing consumption of biopharma products in the region's emerging giants such as China and India. It is one of the most important bioprocessing locations because government policies support the production of local goods along with cheaper manufacturing expenses. Increased spending on single-use technologies and increasing outsourcing of CMC services through more CMOs/CROs are critical drivers. There are several reasons companies opt for bioprocess bags compliance with international quality standards and the need to scale up biosimilars and vaccine production. The region's emphasis on new technologies and export-oriented biomanufacturing also drives adoption even more. On June 1, 2021, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Some of the major players operating in the market include Thermo Fisher Scientific Inc.; Sartorius AG; Merck KGaA; Saint-Gobain; Avantor, Inc.; Corning Incorporated; Lonza Group Ltd.; Entegris; Meissner Filtration Products, Inc.; Charter Medical (Solesis).

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Bioprocess Bags Market
  • 2.2. Research Methodology of the Bioprocess Bags Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL BIOPROCESS BAGS MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

  • 7.1. 2D Bioprocess Bags
  • 7.2. 3D Bioprocess Bags
  • 7.3. Others

8.MARKET INSIGHTS BY PRODUCT TYPE

  • 8.1. Single-Use Bioprocessing Bags
  • 8.2. Multi-Use Bioprocessing Bags

9.MARKET INSIGHTS BY WORKFLOW

  • 9.1. Upstream Process
  • 9.2. Downstream Process
  • 9.3. Process Development
  • 9.4. Media preparation

10.MARKET INSIGHTS BY END USER

  • 10.1. Pharmaceutical & Biopharmaceutical Companies
  • 10.2. CMOs & CROs
  • 10.3. Academic & Research Institutes

11.MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. France
    • 11.2.3. UK
    • 11.2.4. Spain
    • 11.2.5. Italy
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of APAC
  • 11.4. Rest of the World

12.VALUE CHAIN ANALYSIS

  • 12.1. List of Market Participants

13.COMPETITIVE LANDSCAPE

  • 13.1. Competition Dashboard
  • 13.2. Competitor Market Positioning Analysis
  • 13.3. Porter Five Forces Analysis

14.COMPANY PROFILES

  • 14.1. Thermo Fisher Scientific Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Key Financials
    • 14.1.3. SWOT Analysis
    • 14.1.4. Product Portfolio
    • 14.1.5. Recent Developments
  • 14.2. Sartorius AG
  • 14.3. Merck KGaA
  • 14.4. Saint-Gobain
  • 14.5. Avantor, Inc.
  • 14.6. Corning Incorporated
  • 14.7. Lonza Group Ltd.
  • 14.8. Entegris
  • 14.9. Meissner Filtration Products, Inc.
  • 14.10. Charter Medical (Solesis)

15.ACRONYMS & ASSUMPTION

16.ANNEXURE